NASHVILLE, Tenn.–(BUSINESS WIRE)–Melt Pharmaceuticals, Inc. (“Melt”), a clinical-stage pharmaceutical company developing novel approaches for procedural sedation, today announced positive topline results of its pivotal Phase 3 study evaluating the sa…
Author: Business Wire
CrestOptics and Tomocube Partner to Advance 3D Imaging With New Multimodal Imaging Platform
ROME–(BUSINESS WIRE)–CrestOptics S.p.A., a manufacturer of high-end microscopy solutions and advanced systems for fluorescence microscopy, and Tomocube, a leader in holotomography (HT) technology, today announced a strategic collaboration to provide …
Asimov and RevOpsis Therapeutics Sign Licensing Agreement for High Titer Multispecific-Expressing Cell Line
BOSTON & SAN CARLOS, Calif.–(BUSINESS WIRE)–Asimov, the synthetic biology company advancing the design and manufacture of therapeutics, today announced a licensing agreement for its CHO Edge System with RevOpsis Therapeutics (“RevOpsis”), a next-gene…
$4.12 Bn Smart Glasses Market by Monocular & Binocular Glasses, Monochrome, Full-Color Display, Photochromic, Electrochromic, PLD, Suspended Particles Device – Global Forecast to 2030 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Smart Glasses Market by Monocular & Binocular Glasses, Monochrome, Full-Color Display, Photochromic, Electrochromic, Polymer-Dispersed Liquid Crystals (PLD), Suspended Particles Device, Gaming, Remote Inspection, Telem…
PCE Automation Acquiert Olmec-UK
BECCLES, Angleterre–(BUSINESS WIRE)–Fournisseur de solutions d’automatisation, PCE Automation Ltd réalise sa deuxième acquisition en l’espace de deux ans avec Olmec-UK, un fournisseur de services d’inspection par vision et de conversion Web basé dans…
Resumen: PCE Automation adquiere Olmec-UK
BECCLES, Inglaterra–(BUSINESS WIRE)–PCE Automation Ltd, proveedor de soluciones de automatización, completa su segunda adquisición en solo dos años: Olmec-UK, proveedor de inspección por visión y conversión web con sede en el norte de Lincolnshire, e…
Riassunto: PCE Automation rileva Olmec-UK
BECCLES, Inghilterra–(BUSINESS WIRE)–PCE Automation Ltd, impresa che sviluppa soluzioni per l’automazione, ha completato la sua seconda acquisizione in appena due anni aggiungendo al suo portafoglio in espansione Olmec-UK, azienda con sede nel North …
Samenvatting: PCE Automation verwerft Olmec-UK
BECCLES, Engeland–(BUSINESS WIRE)–Verlener op het gebied van automatiseringsoplossingen,PCE Automation Ltd voltooid zijn tweede overname in slechts twee jaar tijd, met de in het noorden van Lincolnshire gelegen verlener op het gebied van vision inspe…
PCE Automation übernimmt Olmec-UK
BECCLES, England–(BUSINESS WIRE)–Der Anbieter von Automatisierungslösungen PCE Automation Ltd schließt seine zweite Übernahme in nur zwei Jahren ab. Der in North Lincolnshire ansässige Anbieter von Sichtprüfungs- und Bahnverarbeitungslösungen Olmec-U…
Health Network One Names Heyward Donigan as New CEO
FT. LAUDERDALE, Fla.–(BUSINESS WIRE)–Health Network One names Heyward Donigan CEO effective Jan 1. Current CEO Luis Mosquera transitions to Exec. Chairman of the Board.
STAAR Surgical to Participate in Stephens Annual Investment Conference (NASH2024)
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, invites investors and the g…
Harrow Launches Access and Affordability Program with Price Reductions for Branded Products
NASHVILLE, Tenn.–(BUSINESS WIRE)—- $HROW–Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced an innovative initiative to expand access and affordability for its ophthalmic pharmaceutical products. This ef…
Kian and RF Announce Formation of US VisionMed Partners, a Nationwide Medically Focused Optometry Platform
CHARLOTTE, N.C. & NEW YORK–(BUSINESS WIRE)–Kian Capital Partners and RF Investment Partners, two lower-middle-market-focused private investment firms, are proud to announce the formation of US VisionMed Partners, a management services organization (M…
GenSight Biologics Announces Submission of LUMEVOQ® Dossier to ANSM to Prepare for Restart of Early Access Program in France
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and cent…
Alcon Reports Solid Third-Quarter 2024 Results, including Double-Digit Earnings Growth and Record Cash Generation
GENEVA–(BUSINESS WIRE)–Alcon Reports Solid Third-Quarter 2024 Results, including Double-Digit Earnings Growth and Record Cash Generation
Alcon Reports Solid Third-Quarter 2024 Results, including Double-Digit Earnings Growth and Record Cash Generation
GENEVA–(BUSINESS WIRE)–Alcon Reports Solid Third-Quarter 2024 Results, including Double-Digit Earnings Growth and Record Cash Generation
Disposable Contact Lenses Focused Insights Market Report 2024-2029 Featuring Prominent Vendors – Alcon, Bausch + Lomb, Johnson & Johnson, and The Cooper Companies – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Disposable Contact Lenses Market – Focused Insights 2024-2029” report has been added to ResearchAndMarkets.com’s offering. The Disposable Contact Lenses Market was valued at USD 7.98 billion in 2023, and is expected to rea…
MediPrint Ophthalmics Presents Promising Results from Phase 2b Clinical Trial of LL-BMT1 for Glaucoma at American Academy of Optometry
INDIANAPOLIS–(BUSINESS WIRE)– #clinicaltrial–MediPrint® Ophthalmics (MediPrint), a clinical-stage ophthalmic drug delivery company based in San Diego, announced the results of the Company’s Phase 2b clinical trial of LL-BMT1. Employing a novel 3D pr…
Viridian Therapeutics Reports Third Quarter 2024 Financial Results and Recent Progress Including New FcRn Data
WALTHAM, Mass.–(BUSINESS WIRE)–Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, today reported recent business highlights and fi…
Harrow Announces Market Access Wins for VEVYE®
NASHVILLE, Tenn.–(BUSINESS WIRE)—- $HROW–Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced its first major market access wins in the 2025 Medicare Part D Prescription Drug Program. Starting January 1, 2…